Anders Eriksson

Anders Eriksson is a Field Application Scientist at Canopy Biosciences since April 2022, with prior experience as the Supervisor of Mobile Laboratories and Application Specialist at CENTOGENE from February 2021 to March 2022. At CENTOGENE, Anders managed the establishment and operation of mobile and permanent laboratories, focusing on high throughput testing for SARS-CoV-2 and developing diagnostic methods. Anders has a strong research background, having served as a Postdoctoral Researcher at Universität Regensburg from February 2018 to December 2020 and at A*STAR - Agency for Science, Technology and Research from June 2015 to October 2017, where contributions included establishing Drosophila melanogaster as a model organism for studying toxic peptides. Anders holds a PhD in Neurovetenskap from Uppsala University, completed in 2015, a Master's degree in Cell and Molecular Biology from Uppsala University, obtained in 2011, and a Bachelor's degree in Molecular Biology from Umeå University, awarded in 2009.